S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|NeoStem Announces Third Quarter 2014 Financial Results and Outlines Near Term Milestones|
|NeoStem Strengthens Executive Management With Appointments of David J. Mazzo, PhD as Chief Executive Officer and Robert S. Vaters as President and Chief Financial Officer and Elects Robin Smith, MD to Executive Chair of the Board|
|NeoStem Receives Drug Manufacture License for Irvine Facility|
|PCT, a NeoStem Company, Presented Lovo(R) Cell Processing System Data at IBC Life Sciences' Commercialization of Cell, Gene & Immunotherapies Conference|
|NeoStem Announces USAN Approval of Generic Name 'Eltrapuldencel-T' for Investigational Patient-Specific Targeted Cancer Immunotherapy|
|NeoStem Data From Phase 2 PreSERVE AMI Clinical Trial to be Presented at American Heart Association Scientific Sessions on November 17|
|Corvus Gold Drills Continues to Expand the Limits of Vein/Stockwork System in the Yellowjacket Deposit, North Bullfrog Project, Nevada (2014/11/20)|
|Corvus Gold Drills 35.9 metres @ 17 g/t Gold and 20 g/t Silver Including 6.7 metres @ 73 g/t Gold (2.1 ounces per ton) and 38 g/t Silver in Shoot Target of the Yellowjacket Deposit, North Bullfrog Project, Nevada (2014/10/28)|
|Corvus Gold Drills 37 metres @ 4 g/t Gold and 75 g/t Silver at Northern Extension of the Yellowjacket Deposit, North Bullfrog Project, Nevada (2015/1/20)|
|NeoStem and Invetech Announce Agreement to Develop Closed Processing System for Cell Therapy Manufacturing|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
Click above to view more mutual fund data and stats for nbs - Neostem Inc.